Thomas Delong
9PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 21, 2025
Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.Jason Groegler, Kaitlin Mangold, Kelli Nicholson
|Jan 17, 2025
Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Individuals.Anita C Hohenstein, Joylynn B Gallegos, Mylinh Dang
|May 29, 2024
The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.Jason Groegler, Aïsha Callebaut, Eddie A James
|Aug 30, 2022
Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.Samantha A Crawford, Timothy A Wiles, Janet M Wenzlau
|Sep 14, 2020
Peptide-Spectrum Match Validation with Internal Standards (P-VIS): Internally-Controlled Validation of Mass Spectrometry-Based Peptide Identifications.Timothy Aaron Wiles, Laura M Saba, Thomas Delong
|Apr 16, 2020
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01.David Arribas-Layton, Perrin Guyer, Thomas Delong
Pageof 2
Frequent Collaborators
6 joint publications
Kathryn Haskins
3 joint publications
Timothy Aaron Wiles
3 joint publications
Rocky L Baker
2 joint publications
Eddie A James
1 joint publications
Roger Powell
1 joint publications
Cole Michel
1 joint publications
K. Scott Beard
1 joint publications
Anita Hohenstein
1 joint publications
Brenda Bradley
1 joint publications
Nichole Reisdorph
